Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.
第一作者:
Changjun,Huang
第一单位:
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
作者:
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);终末期肝病(End Stage Liver Disease);女(雌)性(Female);人类(Humans);肝移植(Liver Transplantation);男(雄)性(Male);中年人(Middle Aged);器官保存(Organ Preservation);试点项目(Pilot Projects);前瞻性研究(Prospective Studies);随机对照试验(主题)(Randomized Controlled Trials as Topic);再灌注损伤(Reperfusion Injury);研究设计(Research Design)
DOI
10.1136/bmjopen-2019-035374
PMID
32376754
发布时间
2021-02-15
- 浏览1

BMJ open
e035374页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文